ストックスクリーナーアプリを入手
6.11
6.26%
0.36
前日終値:
$5.75
開ける：
$5.85
24時間の取引高:
274.31K
Relative Volume:
1.09
時価総額：
$148.56M
収益：
$50.14M
当期純損益:
$-35.38M
株価収益率:
-4.3643
EPS:
-1.4
ネットキャッシュフロー:
$-39.46M
1週間 パフォーマンス:
+8.72%
1か月 パフォーマンス:
-33.66%
6か月 パフォーマンス:
-53.29%
1年 パフォーマンス:
-36.15%
1日の値動き範囲:
$5.75
$6.33
1週間の範囲:
$5.565
$6.33
52週間の値動き範囲:
$5.46
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
RCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
6.11 | 148.56M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | - GuruFocus
D. Boral Capital Reaffirms "Buy" Rating for AVITA Medical (NASDAQ:RCEL) - MarketBeat
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - marketscreener.com
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Stocks in play: Fury Gold Mines Limited - The Globe and Mail
Translational Regenerative Medicine Market Is Booming So Rapidly | Athersys, Avita Medical, AxoGen - openPR.com
Deutsche Bank AG Has $292,000 Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical stock hits 52-week low at $5.54 amid market challenges - Investing.com Canada
Is Abercrombie & Fitch Stock a Buy in June 2025? - The Globe and Mail
Shareholders Will Probably Not Have Any Issues With AVITA Medical, Inc.'s (NASDAQ:RCEL) CEO Compensation - simplywall.st
Is Amazon Stock Ready for a Significant Rebound? - The Globe and Mail
Jane Street Group LLC Sells 36,440 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Delta Investment Management LLC Buys 38,042 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Trading Signals - news.stocktradersdaily.com
Northern Trust Corp Raises Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Will AVITA's Burn Care Breakthroughs Deliver A Healing Touch For Investors? - RTTNews
FY2025 EPS Estimates for AVITA Medical Boosted by Analyst - MarketBeat
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher - MSN
Price T Rowe Associates Inc. MD Sells 9,796 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Updates Bylaws for Governance Enhancement - TipRanks
Cantor Fitzgerald Comments on AVITA Medical FY2025 Earnings - Defense World
(RCEL) Technical Data - news.stocktradersdaily.com
AVITA downgraded by Piper Sandler over sales outlook - MSN
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - The Manila Times
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today - Yahoo Finance
AVITA Medical: Near Perfect Execution Needed To Navigate Through Balance Sheet Challenges - Seeking Alpha
Why AVITA, Botanix, Brainchip, and NAB shares are falling today - The Motley Fool Australia
Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report - Yahoo Finance
Contrasting GBS (NYSE:GBS) and AVITA Medical (NASDAQ:RCEL) - Defense World
Wells Fargo & Company MN Boosts Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Cantor maintains Avita Medical stock Overweight, $19 target post-Q1 By Investing.com - Investing.com Canada
AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance - MSN
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL St - GuruFocus
Avita Medical Shares Decline on 1Q Revenue Miss - MarketWatch
Barclays PLC Purchases 3,526 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita’s Road to Profitability Is in Sight - Morningstar
AVITA Medical (RCEL) Sees Revenue Surge with Product Launches - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
Avita Medical Inc (RCEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):